Biliverdin administration prevents the formation of intimal hyperplasia induced by vascular injury

Circulation

Volumn 112, Issue 4, 2005, Pages 587-591

  Nakao, Atsunori ^a   Murase, Noriko ^a   Ho, Chien ^b   Toyokawa, Hideyoshi ^a   Billiar, Timothy R ^a   Kanno, Shinichi ^a,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Angioplasty; Antioxidants; Apoptosis; Reperfusion; Restenosis

Indexed keywords

BILIVERDIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; AUTOGRAFT; BLOOD VESSEL INJURY; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; IN VITRO STUDY; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; VEIN GRAFT;

ANIMALS; APOPTOSIS; BILIVERDINE; CELL MOVEMENT; ENDOTHELIAL CELLS; HYPERPLASIA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; RATS; RATS, INBRED LEW; TUNICA INTIMA; VASCULAR DISEASES;

EID: 23044447945     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.509778     Document Type: Article

References (28)

1. Lytle BW, Loop FD, Taylor PC, Simpfendorfer C, Kramer JR, Ratliff NB, Goormastic M, Cosgrove DM. Vein graft disease: the clinical impact of stenoses in saphenous vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg. 1992;103:831-840.
2. Vacek JL, Rosamond TL, Stiles HW, Rowe SK, Robuck W, Dittmeier G, Beauchamp GD. Comparison of percutaneous transluminal coronary angioplasty versus coronary artery bypass grafting for multivessel coronary artery disease. Am J Cardiol 1992;69:592-597.
3. Roberts B, McLean GK. Role of percutaneous angioplasty in the treatment of peripheral arterial disease. Adv Surg. 1986;19:329-354.
4. Lefkovits J, Topol EJ. Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention. Prog Cardiovasc Dis. 1997;40:141-158.
5. Berk BC. Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev. 2001;81:999-1030.
6. Otterbein LE, Choi AM. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol. 2000;279: L1029-L1037.
7. Nakao A, Kimizuka K, Stolz DB, Neto JS, Kaizu T, Choi AM, Uchiyama T, Zuckerbraun BS, Nalesnik MA, Otterbein LE, Murase N. Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury. Am J Pathol. 2003;163:1587-1598.
8. Otterbein LE, Zuckerbraun BS, Haga M, Liu F, Song R, Usheva A, Stachulak C, Bodyak N, Smith RN, Csizmadia E, Tyagi S, Akamatsu Y, Flavell RJ, Billiar TR, Tzeng E, Bach FH, Choi AM, Scares MP. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med. 2003;9:183-190.
9. Nakao A, Otterbein LE, Overhaus M, Sarady JK, Tsung A, Kimizuka K, Nalesnik MA, Kaizu T, Uchiyama T, Liu F, Murase N, Bauer AJ, Bach FH. Biliverdin protects the functional integrity of a transplanted syngeneic small bowel. Gatsroenterology. 2004;127:595-606.
10. Nakao A, Neto JS, Kanno S, Stolz DB, Kimizuka K, Liu F, Bach FH, Billiar TR, Choi AM, Otterbein LE, Murase N. Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant. 2005;5:282-291.
11. Szabo G, Fazekas L, Bahrle S, MacDonald D, Stumpf N, Vahl CF, Hagl S. Endothelin-A and -B antagonists protect myocardial and endothelial function after ischemia/reperfusion in a rat heart transplantation model. Cardiovasc Res. 1998;39:683-690.
12. Boyle EM Jr, Pohlman TH, Cornejo CJ, Verrier ED. Endothelial cell injury in cardiovascular surgery: ischemia-reperfusion. Ann Thorac Surg. 1996;62:1868-1875.
13. Murakami S, Toda Y, Seki T, Munetomo E, Kondo Y, Sakurai T, Furukawa Y, Matsuyama M, Nagate T, Hosokawa N, Nagata K. Heat shock protein (HSP) 47 and collagen are upregulated during neointimal formation in the balloon-injured rat carotid artery. Atherosclerosis. 2001; 157:361-368.
14. Sato Y, Rifkin DB. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-β1-like molecule by plasmin during co-culture. J Cell Biol. 1989; 109:309-315.
15. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
16. Schwartz SM, Stemerman MB, Benditt EP. The aortic intima, II: repair of the aortic lining after mechanical denudation. Am J Pathol. 1975;81: 15-42.
17. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
18. Clowes AW, Clowes MM, Reidy MA. Kinetics of cellular proliferation after arterial injury, III: endothelial and smooth muscle growth in chron-ically denuded vessels. Lab Invest. 1986;4:295-303.
19. Tulis DA, Durante W, Liu X, Evans AI, Peyton KJ, Schafer AI. Adenovinis-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation. 2001;104: 2710-2715.
20. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235:1043-1046.
21. Baranano DE, Rao M, Ferns CD, Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA. 2002;99: 16093-16098.
22. Sedlak TW, Snyder SH. Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics. 2004;113: 1776-1782.
23. Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, Yodoi J. Redox control of cell death. Antioxid Redox Signal. 2002;4:405-414.
24. 2- terminal kinase activity improves ischemia/reperfusion injury in rat lungs. J Immunol. 2004;172:2569-2577.
25. Kunduzova OR, Bianchi P, Pizzinat N, Escourrou G, Seguelas MH, Parmi A, Cambon C. Regulation of JNK/ERK activation, cell apoptosis, and tissue regeneration by monoamine oxidases after renal ischemia-reperfusion. FASEB J. 2002;16:1129-1131.
26. Stocker R. Antioxidant activities of bile pigments. Antioxid Redox Signal. 2004;6:841-849.
27. Wennberg RP. Cellular basis of bilirubin toxicity. N Y State J Med. 1991;91:493-496.
28. Kato Y, Shimazu M, Kondo M, Uchida K, Kumamoto Y, Wakabayashi G, Kitajima M, Suematsu M. Bilirubin rinse: a simple protectant against the rat liver graft injury mimicking heme oxygenase-1 preconditioning. Hepatology. 2003;38:364-373.